#ProstateCancer, #Ozempic, & Lifestyle | Kristin Geiger, FNP-BC & #AlexScholz #PCRI

Donate to PCRI: https://pcri.org/donate/ For more information, visit https://pcri.org 0:24 How can prostate cancer patient with a higher BMI benefit from weight loss drugs? 2:01 What about patients with a higher BMI who are on hormone therapy? 3:01 What is the dosage and is the patient injecting themselves a problem? 5:36 What about anti-nausea medication? 5:53 Are there any other side effects? 7:40 What are the percentages of patients experiencing side effects? 9:15 What is the frequency and location of injections? 9:49 Are there any counter-interactions with other medications? 11:02 What duration do patients stay on these drugs? 13:31 How often does weight gain return? 15:17 If I take these drugs and lose weight will it make my cancer treatments better? 16:17 What about the unknown issues of these new drugs? 19:16 What about dietary recommendations? 20:56 Alex's conclusions 21:24 If you need more help Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org To learn more about prostate cancer, visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.